title: Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure?
authors.affiliation: Dendrix Research, Rua Joaquim Floriano, 72/24-04534-000 Sao Paulo, Brazil. everardo@dendrix.com.br
authors.forename: Everardo D
authors.initials: ED
authors.lastname: Saad
authors.forename: Marc
authors.initials: M
authors.lastname: Buyse
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D018572:Disease-Free Survival; D023381:Endpoint Determination; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D011634:Public Health / Q000706:statistics & numerical data; D016019:Survival Analysis; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents